AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 150 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,502,000 | +57.5% | 144,877 | +25.2% | 0.00% | +50.0% |
| Q3 2019 | $2,224,000 | -30.8% | 115,720 | +6.4% | 0.00% | -33.3% |
| Q2 2019 | $3,213,000 | -19.5% | 108,735 | +29.4% | 0.00% | -25.0% |
| Q1 2019 | $3,991,000 | +23.6% | 84,015 | -6.1% | 0.00% | 0.0% |
| Q4 2018 | $3,228,000 | -29.1% | 89,429 | +20.9% | 0.00% | 0.0% |
| Q3 2018 | $4,552,000 | -6.5% | 73,957 | +2.6% | 0.00% | -20.0% |
| Q2 2018 | $4,867,000 | +59.3% | 72,057 | +27.9% | 0.01% | +66.7% |
| Q1 2018 | $3,056,000 | +52.3% | 56,339 | +67.7% | 0.00% | +50.0% |
| Q4 2017 | $2,007,000 | +70.4% | 33,588 | +38.6% | 0.00% | +100.0% |
| Q3 2017 | $1,178,000 | -6.7% | 24,236 | +0.9% | 0.00% | 0.0% |
| Q2 2017 | $1,262,000 | -40.9% | 24,008 | -49.0% | 0.00% | -50.0% |
| Q1 2017 | $2,137,000 | +19.3% | 47,119 | -0.4% | 0.00% | 0.0% |
| Q4 2016 | $1,791,000 | -5.5% | 47,314 | -5.8% | 0.00% | 0.0% |
| Q3 2016 | $1,895,000 | -48.2% | 50,206 | -57.0% | 0.00% | -50.0% |
| Q1 2015 | $3,661,000 | – | 116,829 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |